Boncresa (denosumab-mobz)
Biosimilar
- Region
- 🇺🇸 US
- Active substance
- denosumab-mobz
- Company
- Amneal Pharms Llc
- Status
- Approved
- FDA approval
- Fri 19 Dec 2025
- Designations
- Biosimilar
- Application
- BLA761456
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Fri 19 Dec 2025🇺🇸 FDA approval
FDA approves biosimilar Boncresa (denosumab-mobz)
Amneal Pharms Llc; BLA761456; Biosimilar; injectable · source
Same substance in other markets
- 🇺🇸 Oziltus Approved · Amneal Pharms Llc
Follow Boncresa
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.